12 Best Global Stocks to Buy According to Hedge Funds

Page 6 of 12

7. Novo Nordisk A/S (NYSE:NVO)

Number of Hedge Fund Holders: 64

Novo Nordisk A/S (NYSE:NVO) is a global healthcare company with more than 95 years of innovation and leadership in diabetes care. The company reported sales in North American operations increased by 30% in the Danish kroner (30% at CER), and sales in International Operations increased by 17% in the Danish kroner (19% at CER) for the fiscal year 2024. In January, the company announced positive results from a phase 1b/2a trial of amycretin, a once-weekly GLP-1 and amylin receptor agonist. The trial evaluated the drug’s safety, tolerability, pharmacokinetics, and effectiveness in 125 participants with overweight or obesity problems.

Page 6 of 12